Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecular therapeutics for oncology and other unmet medical needs. The company was founded by Jim Wells[1],[2].
Founded in 1998, Sunesis filed and completed an IPO in 2005. It is listed on NASDAQ as SNSS. [1]